Abstract
Background:
Preterm prelabor rupture of the fetal membranes (PPROM) is a significant contributor to the morbidity and mortality of preterm birth, particularly in the setting of chorioamnionitis. No sensitive or specific diagnostic or predictive test currently exists for the accurate diagnosis of chorioamnionitis. Our aim was to measure messenger RNA (mRNA) coding cytokines in the maternal blood and examine whether they were increased in association with chorioamnionitis at delivery.
Methods/Results:
We performed a prospective cohort study of women recruited with PPROM at a mean gestational age of 28.9 weeks at risk of developing chorioamnionitis. Blood was sampled from participants, and the expression of mRNA coding for proinflammatory genes was measured in women with and without chorioamnionitis at the time of delivery as well as gestation-matched healthy controls. Expression was measured using quantitative polymerase chain reaction (PCR) and also digital PCR. Interleukin 1β (IL1B) mRNA expression in maternal blood was elevated in women with chorioamnionitis compared to gestation-matched controls. Importantly, among women admitted with PPROM, digital PCR confirmed a significant increase in IL1B expression in maternal blood in women with chorioamnionitis compared to women without chorioamnionitis. Polymerase chain reaction array revealed that CD14, nuclear factor of κ light polypeptide gene enhancer in B-cells 1 (NFKB1), and tumor necrosis factor receptor super family-interacting serine–threonine kinase 1 mRNA were significantly increased in women with chorioamnionitis compared to controls. Digital PCR confirmed that NFKB1 mRNA was significantly increased in patients with chorioamnionitis compared to controls and that CD14 levels increased over time in patients with PPROM having chorioamnionitis.
Conclusion:
Measuring circulating proinflammatory mRNA in women with PPROM may distinguish those with chorioamnionitis from those without, in turn providing better targeted therapies and appropriate timing of delivery.
Similar content being viewed by others
References
Goldenberg RL, Culhane JF, Lams JD, Romero R. Preterm Birth 1 Epidemiology and causes of preterm birth. Lancet. 2008; 371(9606):75–84.
Czikk MJ, McCarthy FP, Murphy KE. Chorioamnionitis: from pathogenesis to treatment. Clin Microbiol Infect. 2011; 17(9): 1304–1311. doi:10.1111/j.1469–0691.2011.03574.X.
Ramsey PS, Lieman JM, Brumfield CG, Carlo W. Chorioamnionitis increases neonatal morbidity in pregnancies complicated by preterm premature rupture of membranes. Am J Obstet Gynecol. 2005; 192(4):1162–1166. doi:10.1016/j.ajog.2004.11.035.
Andrews WW, Cliver SP, Biasini F, et al. Early preterm birth: association between in utero exposure to acute inflammation and severe neurodevelopmental disability at 6 years of age. Am J Obstet Gynecol. 2008; 198(4):466.e1–466.ell. doi:10.1016/j. ajog.2007.12.031.
Shatrov JG, Birch SCM, Lam LT. Chorioamnionitis and Cerebral Palsy. Obstet Gynecol. 2010;116(2):387–392.
Kallapur SG, Presicce P, Chougnet CA, Rueda CM, Jobe AH. Fetal Immune Response to Chorioamnionitis. Semin Reprod Med. 2014;32(1):56–67.
Ng EKO, Tsui NBY, Lau TK, et al. mRNA of placental origin is readily detectable in maternal plasma. Proc Natl Acad Sci USA. 2003; 100(8):4748–4753.doi:10.1073/pnas.0637450100.
Kim YM, Romero R, Chaiworapongsa T, et al. Toll-like receptor-2 and -4 in the chorioamniotic membranes in spontaneous labor at term and in preterm parturition that are associated with chorioamnionitis. Am J Obstet Gynecol. 2004; 191(4):1346–1355. doi:10. 1016/j.ajog.2004.07.009.
Menon R, Taylor RN, Fortunato SJ. Chorioamnionitis-a complex pathophysiologic syndrome. Placenta. 2010; 31(2):113–120. doi: 10.1016/j.placenta.2009.11.012.
Whale AS, Huggett JF, Cowen S, et al. Comparison of microfluidic digital PCR and conventional quantitative PCR for measuring copy number variation. Nucleic Acids Res. 2012; 40(11):e82. doi:10.1093/nar/gks203.
Trochez-Martinez RD, Smith P, Lamont RF. Use of C-reactive protein as a predictor of chorioamnionitis in preterm prelabour rupture of membranes: a systematic review. BJOG. 2007; 114(7):796–801.doi:10.1111/j.1471–0528.2007.01385.x.
Van de Laar R, van der Ham DP, Oei SG, Willekes C, Weiner CP, Mol BW. Accuracy of C-reactive protein determination in predicting chorioamnionitis and neonatal infection in pregnant women with premature rupture of membranes: a systematic review. Eur J Obs Gynecol Reprod Biol. 2009; 147(2): 124–129. doi:10.1016/j.ejogrb.2009.09.017.
Gulati S, Agrawal S, Raghunandan C, et al. Maternal serum interleukin-6 and its association with clinicopathological infectious morbidity in preterm premature rupture of membranes: a prospective cohort study. J Matern Fetal Neonatal Med. 2012; 25(8): 1428–1432. doi: 10.3109/14767058.2011.638952.
Holst RM, Laurini R, Jacobsson B, et al. Expression of cytokines and chemokines in cervical and amniotic fluid: relationship to histological chorioamnionitis. J Matern Fetal Neonatal Med. 2007; 20(12):885–893.doi:10.1080/14767050701752601.
Lacerte M, Bujold E, Audibert F, Mayrand M-H. Amniocentesis for PPROM management: a feasibility study. J Obstet Gynaecol Can. 2008; 30(8):659–664. Web site, http://www.ncbi.nlm.nih.gov/pubmed/18786287. Accessed July 15, 2014.
Mcintosh JJ, McHugh K, Haas DM. Difficulties in establishing routine amniocentesis for preterm labor evaluation. J Matern Fetal Neonatal Med. 2012; 25(3):313–314. doi:10.3109/14767058.2011. 573826.
Dinarello CA. Immunological and inflammatory functions of the interleukin-1 family. Annu Rev Immunol. 2009;27:519–550. doi: 10.1146/annurev.immunol.021908.132612.
Van de Veerdonk FL, Netea MG, Dinarello CA, Joosten LA. Inflammasome activation and IL-1β and IL-18 processing during infection. Trends Immunol. 2011; 32(3):110–116. doi:10.1016/j.it. 2011.01.003.
Bowen JM, Chamley L, Keelan JA, Mitchell MD. Cytokines of the placenta and extra-placental membranes: roles and regulation during human pregnancy and parturition. Placenta. 2002; 23(4): 257–273. doi:10.1053/plac.2001.0782.
Sadowsky DW, Adams KM, Gravett MG, Witkin SS, Novy MJ. Preterm labor is induced by intraamniotic infusions of interleukin-1 beta and tumor necrosis factor-alpha but not by interleukin-6 or interleukin-8 in a nonhuman primate model. Am J Obstet Gynecol. 2006; 195(6):1578–1589. doi:10.1016/j.ajog. 2006.06.072.
Ashur-Fabian O, Yerushalmi GM, Mazaki-Tovi S, et al. Cell free expression of hifl alpha and p21 in maternal peripheral blood as a marker for preeclampsia and fetal growth restriction. PLoS One. 2012; 7(5):e37273. doi:10.1371/journal.pone. 0037273.
Hahn S, Rusterholz C, Hosli I, Lapaire O. Cell-free nucleic acids as potential markers for preeclampsia. Placenta. 2011;32 suppl: S17–S20. doi:10.1016/j.placenta.2010.06.018.
Pang WW, Tsui MH, Sahota D, et al. A strategy for identifying circulating placental RNA markers for fetal growth assessment. Prenat Diagn. 2009; 29(5):495–504. doi:10.1002/pd.2230.
Whitehead C, Teh WT, Walker SP, et al. Quantifying circulating hypoxia-induced RNA transcripts in maternal blood to determine in utero fetal hypoxic status. BMC Med. 2013;11:256.
Lanoix D, Lacasse A-A, St-Pierre J, et al. Quantitative PCR pitfalls: the case of the human placenta. Mol Biotechnol. 2012; 52(3):234–243. doi:10.1007/s12033-012-9539-2.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Stock, O., Gordon, L., Kapoor, J. et al. Chorioamnionitis Occurring in Women With Preterm Rupture of the Fetal Membranes Is Associated With a Dynamic Increase in mRNAs Coding Cytokines in the Maternal Circulation. Reprod. Sci. 22, 852–859 (2015). https://doi.org/10.1177/1933719114565034
Published:
Issue Date:
DOI: https://doi.org/10.1177/1933719114565034